Xceleron (Chapter 11)

Xceleron (Chapter 11)

Xceleron (Chapter 11)

14C AMS analytical tech & clinical design - R&D efficiency - translational science, target turnover, preclinical, Phase 0, enriched Phase I & Phase II/III
Founded
1997
Raised
$10M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$2,400,000
Venture capital - 2012
Undisclosed amount
Undisclosed funding - 2010
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Xceleron (Chapter 11) makes some noise.